Institutional investors hold a majority ownership of A through the 86.15% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended April 2015, these large investors purchased a net $261.3 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM BELGIUM SA Bought 318.6 Thousand shares of Agilent Technologies Inc